4//SEC Filing
MOORE ALISON 4
Accession 0001214659-21-003605
CIK 0001737287other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:53 PM ET
Size
6.9 KB
Accession
0001214659-21-003605
Insider Transaction Report
Form 4
MOORE ALISON
Chief Technical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-26+92,365→ 92,365 totalExercise: $33.78Exp: 2031-03-26→ Common Stock (92,365 underlying) - Award
Common Stock
2021-03-26+24,866→ 127,440 total
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on March 13, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001754937
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 4:53 PM ET
- Size
- 6.9 KB